| Name | microRNA 548at |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMIR548AT (also known as miR-548at-5p) is a microRNA that has been examined for its role in disease susceptibility, particularly in Parkinson’s disease (PD). In a case‐control study involving a Chinese Han population, researchers investigated a single‐nucleotide polymorphism (rs11651671:A>G) in MIR548AT and found no statistically significant association with PD risk. This finding suggests that, at least in this population, MIR548AT does not appear to contribute substantially to PD genetic susceptibility."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nWhile the direct function of MIR548AT in PD remains inconclusive, its evaluation is set against a broader context of RNA-based regulation as demonstrated in several studies. For instance, research into intron retention mechanisms showed that RNA-binding proteins like BUD13 facilitate proper splicing and consequent gene expression, thereby impacting immune responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Similarly, a study in glioblastoma underscored how the BUD13/CDK12/MBNL1 axis plays a key role in tumor vasculogenic mimicry, suggesting that dysregulation of post-transcriptional regulators can have profound cellular consequences."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther illustrating the importance of RNA regulatory networks, investigations in colorectal cancer have revealed that long non-coding RNAs can recruit proteins such as BUD13 to stabilize target mRNAs and activate oncogenic signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Although these studies primarily focus on other aspects of RNA regulation, they provide important context for understanding the complex interplay of microRNAs like MIR548AT within cellular regulatory systems. Thus, while MIR548AT’s specific impact on PD susceptibility appears limited based on current evidence, further research is necessary to elucidate its broader functional roles across different biological processes and disease contexts.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Fang Li, Han Liu, Yuan Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of variants in microRNA with Parkinson's disease in Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10072-017-3210-4"}], "href": "https://doi.org/10.1007/s10072-017-3210-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29209904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29209904"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Luke Frankiw, Devdoot Majumdar, Christian Burns, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BUD13 Promotes a Type I Interferon Response by Countering Intron Retention in Irf7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2018.11.038"}], "href": "https://doi.org/10.1016/j.molcel.2018.11.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30639243"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30639243"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Meichen Liu, Xuelei Ruan, Xiaobai Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-022-05426-z"}], "href": "https://doi.org/10.1038/s41419-022-05426-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36463205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36463205"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shengwei Zhuang, Weihong Lu, Lianjun Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RNASEH1-AS1 induced by H3K27ac stabilizes ANXA2 mRNA to promote the progression of colorectal cancer through recruiting BUD13."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2023_230612N303"}], "href": "https://doi.org/10.4149/neo_2023_230612N303"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38053379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38053379"}]}]}]}
|
| NCBI Gene ID | 100847030 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR548AT has 105 functional associations with biological entities spanning 1 categories (cell line, cell type or tissue) extracted from 1 datasets.
Click the + buttons to view associations for MIR548AT from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR548AT gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |